Biotech Earnings Preview: A Place to Hide? (at TheStreet.com)

Third-quarter results that will begin to roll in from biotech companies Tuesday have taken on new importance, as investors look to see if drug stocks will be a safe haven in the panic-stricken market. Large-cap names are expected to perform at least in line with expectations, with some showing upside despite seasonality and pushback from a strengthening dollar. According to the Credit Suisse biotech team, prescription data suggest that the... [read full story]